Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05793541 · ClinicalTrials.gov registry record · NA

Just-in-time Interventions for Reducing Short-term Suicide Risk

A NA study of Suicide, sponsored by Massachusetts General Hospital.

Recruiting
Registry status
NA
Development phase
185
Enrollment target
1
Study location

NCT05793541 is a NA study of Suicide that is actively recruiting participants, run by Massachusetts General Hospital. The registered enrollment target is 185 participants, below the 6,988-participant average among 92 other Suicide trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05793541, a NA study of Suicide, is actively recruiting participants, sponsored by Massachusetts General Hospital.

RECRUITING
Registry status
NA
Development phase
185 participants
Enrollment target
1
Study location

Study Summary

The goal of this study is to test the effects of just-in-time intervention strategies aimed to promote implementation of the safety plan and its components at different levels of suicidal urges and intent. The main questions the investigators aim to answer are: 1. What is the acceptability and feasibility of the just-in-time intervention strategies? 2. What are the proximal effects of just-in-time intervention strategies aimed to promote use of the safety plan and its components? 3. What internal and external contextual factors moderate the just-in-time intervention effects? Participants (adults hospitalized for suicidal thoughts or behaviors) will: * Answer questions about current suicidal thoughts on their smartphone up to 4 times each day during both hospitalization and the 4 weeks after they leave the hospital * Each time they submit a survey, be immediately randomized to receive (or not receive) a just-in-time intervention tailored to their level of current suicidal thoughts * Answer brief follow-up questions on their smartphone within a couple hours of each randomization * Provide feedback on their experience with the just-in-time interventions

Conditions Studied

Suicide

Interventions

  • BEHAVIORAL Phone call
  • BEHAVIORAL Text messaging
  • BEHAVIORAL Automated interactive smartphone-based tool
  • BEHAVIORAL Non-interactive pop-up messages

Study Locations (1)

Massachusetts

  • Mass General Brigham - Boston

Trial Details

FieldValue
Enrollment Target 185 participants
Start Date 2024-11-19
Est. Completion 2026-12
Phase NA

Sponsor

Massachusetts General Hospital

2,032 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05793541

The ClinicalTrials.gov registry entry for NCT05793541 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 185 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 6,988-participant average among 92 other Suicide trials with a reported enrollment target (97% lower). The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Suicide appearing as the primary indexed condition, and to 4 interventions - of which Phone call is the first listed.

NCT05793541 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT05793541 about?

NCT05793541 is a clinical study titled "Just-in-time Interventions for Reducing Short-term Suicide Risk". The goal of this study is to test the effects of just-in-time intervention strategies aimed to promote implementation of the safety plan and its components at different levels of suicidal urges and intent. The main questions the investigators aim to answer are: 1. What is the acceptability and feas...

What is the current status of trial NCT05793541?

This trial is currently recruiting. It is a NA study. The enrollment target is 185 participants. The study started on 2024-11-19. Estimated completion is 2026-12.

What conditions does trial NCT05793541 study?

This clinical trial studies the following conditions: Suicide.

What interventions are being tested in trial NCT05793541?

The interventions under investigation include: Phone call (BEHAVIORAL), Text messaging (BEHAVIORAL), Automated interactive smartphone-based tool (BEHAVIORAL), Non-interactive pop-up messages (BEHAVIORAL).

Who is sponsoring clinical trial NCT05793541?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05793541 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Suicide

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Suicide

All registered trials for this condition

Massachusetts

All trials with a study site in Massachusetts

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.